Ratiograstim 48 MIU/0
As listed in the register: Ratiograstim 48 MIU/0,8ml, oplossing voor injectie of infusie
oplossing voor injectie, concentraat voor oplossing voor infusie
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Filgrastim
- Made by
- ratiopharm GmbH
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (NEUPOGEN). It describes the substance, not this exact product.
Colony-stimulating factors are glycoproteins which act on hematopoietic cells by binding to specific cell surface receptors and stimulating proliferation, differentiation commitment, and some end-cell functional activation.
Endogenous G-CSF is a lineage-specific colony-stimulating factor that is produced by monocytes, fibroblasts, and endothelial cells.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-07-23
Safety of the active substance
From the US prescribing label for the same active substance (NEUPOGEN). It describes the substance, not this exact product.
- NEUPOGEN is contraindicated in patients with a history of serious allergic reactions to human granulocyte colony-stimulating factors such as filgrastim or pegfilgrastim [see Warnings and Precautions (5.3) ].
- Patients with a history of serious allergic reactions to human granulocyte colony-stimulating factors such as filgrastim or pegfilgrastim.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
FranceNo exact match for this strength and form
CanadaNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | ratiopharm GmbH |
|---|---|
| Active substance | Filgrastim |
| Used in | Cancer treatments and immune-system medicines |
| Form | oplossing voor injectie, concentraat voor oplossing voor infusie |
| Classification | L03AA02 · Cancer treatments and immune-system medicines |
| Route | intraveneus gebruik, subcutaan gebruik |
| Dispensing (as stated by the register) | Uitsluitend recept |
| Name in the register | Ratiograstim 48 MIU/0,8ml, oplossing voor injectie of infusie |
| RVG | EU/1/08/444 |
Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician
Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.